Anaphylactoid reactions / anaphylaxis (includes anaphylactic shock)

• (2021): Nguyen KD+, J Clin Pharm Ther Feb, Online ahead of print [REVIEW]
• (2015): Jares EJ+, J Allergy Clin Immunol Pract 3(5), 78014%
• (2015): Stark MA+, J Obstet Gynecol Neonatal Nurs 44(5), 610

DRESS syndrome (Drug-induced hypersensitivity syndrome)

• (2010): Um SJ+, J Investig Allergol Clin Immunol 20(7), 556

Exanthems

• (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5346%

Fixed eruption / fixed drug eruption

• (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5360%

Hypersensitivity

• (2020): Schrüfer P+, Allergy Asthma Clin Immunol 16(1), 102
• (2014): Romano A+, J Allergy Clin Immunol Pract 2(1), 3

Urticaria / hives

• (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5347%

Neurological adverse effect / neurological deficit

• (2017): Deshayes S+, Drug Saf 40(12), 1171-1198 [REVIEW]

Neurotoxicity

• (2014): Mattappalil A+, Clin Ther 36(11), 1489 [REVIEW]

Agranulocytosis / severe selective neutropenia

• (2017): Andres E+, QJM Jan, Epub ahead of print
• (2014): Curtis BR, Immunohematology 30(2), 95 [REVIEW]

Neutropenia (neutrophils decreased)

• (2019): Vial T+, Fundam Clin Pharmacol 33(2), 225-231
• (2014): Curtis BR, Immunohematology 30(2), 95 [REVIEW]

Adverse effects / adverse reactions

• (2015): Olson SC+, J Pediatric Infect Dis Soc 4(2), 119
• Negative findings
• (2024): Moreal C+, New Microbiol 47(3), 227-242 [REVIEW]